U.S. stocks rose Tuesday, with the Standard & Poor’s 500 Index rebounding from its worst slump since June, fueled by earnings at companies from Pfizer Inc. to D.R. Horton Inc. topping estimates and consumer confidence rising. The S&P 500 (SPX) rose 0.6 percent to 1,792.50, while the Dow Jones Industrial Average climbed 90.68 points, or 0.6 percent, to 15,928.56. About 6.6 billion shares changed hands on U.S. exchanges, 6.8 percent more than the three-month average. Pfizer, the world’s biggest drugmaker, jumped 2.6 percent after its earnings beat estimates as it cut costs and benefitted from a reduced tax rate. An index of homebuilders surged 5.3 percent as D.R. Horton jumped 9.8 percent and a report showed home prices climbed. American International Group Inc. rose 2.5 percent after Bank of America Corp. announced it expects the insurer to buy back $10 billion of stock during the next two years. But Apple Inc. tumbled 8 percent as iPhone sales trailed estimates. Wednesday’s trading will be affected by results of the last Federal Reserve policy meeting led by outgoing Chairman Ben Bernanke, who will be succeeded by Janet Yellen on Feb. 1.
Jim Woods has over 20 years of experience in the markets from working as a stockbroker, financial journalist, and money manager. As well as a book author and regular contributor to numerous investment websites, Jim is the editor of:
Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.
Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:
Jon Johnson's philosophy in investing and trading is to take what the market gives you regardless if that is to the upside or downside. For the past 21 years, Jon has helped thousands of clients gain success in the financial markets through his newsletters and education services:
Get free access to "Millionaire Maker" Hilary Kramer's latest report 3 Biotech Breakthroughs To Bank On. Simply tell us where to send it in the box below.
*Along with my FREE report, Hilary Kramer's 3 Biotech Breakthroughs to Bank On, please also send Hilary's free weekly e-letter, Trading Desk. We value your privacy. You will not be spammed, ever. Period.